Kodiak Sciences (KOD) Change in Acquisitions & Divestments (2019 - 2023)
Kodiak Sciences' (KOD) quarterly Change in Acquisitions & Divestments came in at $105.0 million in Q2 2023, down 55.32% on a QoQ basis from $235.0 million in Q1 2023.
Analysis
Kodiak Sciences (KOD) Change in Acquisitions & Divestments (2019 - 2023) Analysis & Trends
Kodiak Sciences (KOD) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $105.0 million in Q2 2023.
- Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $105.0 million in Q2 2023, while the trailing twelve-month figure through Mar 2024 was $105.0 million (down 71.85% YoY) and the FY2023 annual result came in at $340.0 million, up 146.38% from the prior year.
- Change in Acquisitions & Divestments slipped to $105.0 million in Q2 2023, from $235.0 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $235.0 million in Q1 2023 to a low of -$2.4 million in Q4 2019.
- A 5-year average of $58.6 million and a median of $57.4 million in 2020 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2020 — Change in Acquisitions & Divestments jumped 2766.71% — and 2021, when it plunged 85.05%.
- Tracing KOD's Change in Acquisitions & Divestments over 5 years: stood at -$2.4 million in 2019, then jumped by 2766.71% to $64.0 million in 2020, then plunged by 86.72% to $8.5 million in 2021, then soared by 747.06% to $72.0 million in 2022, then soared by 45.83% to $105.0 million in 2023.
- The last three Change in Acquisitions & Divestments figures came in at $105.0 million (Q2 2023), $235.0 million (Q1 2023), and $72.0 million (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Kodiak Sciences | 2.21 Bn | 2.21 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 105.00 Mn |
| Mar 31, 2023 | 235.00 Mn |
| Dec 31, 2022 | 72.00 Mn |
| Sep 30, 2022 | 66.00 Mn |
| Jun 30, 2021 | 8.50 Mn |
| Mar 31, 2021 | 16.00 Mn |
| Dec 31, 2020 | 64.00 Mn |
| Sep 30, 2020 | 58.00 Mn |
| Jun 30, 2020 | 56.85 Mn |
| Mar 31, 2020 | 19.30 Mn |
| Dec 31, 2019 | -2.40 Mn |
| Sep 30, 2019 | 4.80 Mn |